Clinical Trials in Baltimore

Showing 3981-4000 of 23,476 trials

Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus

NCT00431756

The purpose of this study is to determine if there are any early changes in DNA markers of blood and esophageal tissue in people with gastric reflux, Barrett's esophagus or esophageal cancer that can warn of a progression to esophageal cancer.

Barrett EsophagusEsophageal NeoplasmGastroesophageal Reflux

Johns Hopkins University600 participantsStarted May 2002

Baltimore, Maryland, United States

COMPLETEDPhase 2< 1 mile

Nirogacestat in Ovarian Granulosa Cell Tumors

NCT05348356

This phase 2 clinical trial will study the effectiveness of nirogacestat in ovarian granulosa cell tumors (OvGCTs). Nirogacestat is a gamma secretase inhibitor (GSI) which is hypothesized to decrease the growth and activity of ovarian granulosa tumors.

Ovarian Granulosa-Stromal TumorOvarian Granulosa Cell TumorOvarian Cancer

SpringWorks Therapeutics, Inc.53 participantsStarted Aug 2022

Los Angeles, California, United States • Los Angeles, California, United States • Orlando, Florida, United States +18 more locations

Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus

Nirogacestat in Ovarian Granulosa Cell Tumors

Find Trials by Condition in Baltimore

IVTCC 2.0: A Prospective Multicenter Ventricular Tachycardia Catheter Ablation Registry

An Interventional Study of Infigratinib in Children With Hypochondroplasia

Comparative Effectiveness of ECT vs. KETAMINE Over the Lifespan

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.

Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer.

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014)

Mobile Sensor Technologies to Assess General Symptomology of People With Cancer

An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)

COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"

Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma

First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer

ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients

Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial

A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC

Lisocabtagene Maraleucel, Nivolumab and Ibrutinib for the Treatment of Richter's Transformation

A Phase 1/2 Study of D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutations

Acceptability and Safety of MR-C-014 in Persons With Neuromyelitis Optica Spectrum Disorder